The release was transmitted with an incorrect boilerplate for Stimwave by Stimwave Technologies.
Sept. 24, 2019 00:36 UTC
--(BUSINESS WIRE)-- Stimwave Technologies requests that their press release NewsItemId: 20190918005973 issued September 18, 2019 “Stimwave Launches Post-Market Peripheral Neuropathy Pain Relief Randomized Controlled Trial for Pain Awareness Month” be killed.
The release was transmitted with an incorrect boilerplate for Stimwave by Stimwave Technologies.
A replacement release will not be issued.
Contacts
Lori Puccinelli Stern, Rosemary O’Brien and Sarah Rogers, Glodow Nead Communications, (415) 394-6500, StimwavePR@GlodowNead.com
Source:
View this news release online at:
http://www.businesswire.com/news/home/20190918005973/en